164 related articles for article (PubMed ID: 24579243)
1. Plasma level monitoring of the major metabolites of diacetylmorphine (heroin) by the "chasing the dragon" route in severe heroin addicts.
Dubois N; Demaret I; Ansseau M; Rozet E; Hubert P; Charlier C
Acta Clin Belg; 2013; 68(5):359-67. PubMed ID: 24579243
[TBL] [Abstract][Full Text] [Related]
2. [Efficacy diacetylmorphine (pharmaceutical heroin) for heroin treatment ].
Demaret I; Lemaître A; Ansseau M
Rev Med Liege; 2010 Dec; 65(12):681-7. PubMed ID: 21287763
[TBL] [Abstract][Full Text] [Related]
3. The quantitative analysis of heroin, methadone and their metabolites and the simultaneous detection of cocaine, acetylcodeine and their metabolites in human plasma by high-performance liquid chromatography coupled with tandem mass spectrometry.
Rook EJ; Hillebrand MJ; Rosing H; van Ree JM; Beijnen JH
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Sep; 824(1-2):213-21. PubMed ID: 16103023
[TBL] [Abstract][Full Text] [Related]
4. Methadone maintenance treatment: a protective factor for cocaine injection in a street-recruited cohort of heroin users.
Bravo MJ; Llorens N; Barrio G; Brugal MT; Santos S; Sordo L; de la Fuente L;
Drug Alcohol Depend; 2010 Nov; 112(1-2):62-8. PubMed ID: 20591582
[TBL] [Abstract][Full Text] [Related]
5. Heroin reduces startle and cortisol response in opioid-maintained heroin-dependent patients.
Walter M; Wiesbeck GA; Degen B; Albrich J; Oppel M; Schulz A; Schächinger H; Dürsteler-MacFarland KM
Addict Biol; 2011 Jan; 16(1):145-51. PubMed ID: 20331562
[TBL] [Abstract][Full Text] [Related]
6. Controlled trial of prescribed heroin in the treatment of opioid addiction.
March JC; Oviedo-Joekes E; Perea-Milla E; Carrasco F;
J Subst Abuse Treat; 2006 Sep; 31(2):203-11. PubMed ID: 16919749
[TBL] [Abstract][Full Text] [Related]
7. Arterial and venous pharmacokinetics of intravenous heroin in subjects who are addicted to narcotics.
Rentsch KM; Kullak-Ublick GA; Reichel C; Meier PJ; Fattinger K
Clin Pharmacol Ther; 2001 Sep; 70(3):237-46. PubMed ID: 11557911
[TBL] [Abstract][Full Text] [Related]
8. Supervised injectable heroin or injectable methadone versus optimised oral methadone as treatment for chronic heroin addicts in England after persistent failure in orthodox treatment (RIOTT): a randomised trial.
Strang J; Metrebian N; Lintzeris N; Potts L; Carnwath T; Mayet S; Williams H; Zador D; Evers R; Groshkova T; Charles V; Martin A; Forzisi L
Lancet; 2010 May; 375(9729):1885-95. PubMed ID: 20511018
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of Heroin-assisted Treatment In Belgium: A Randomised Controlled Trial.
Demaret I; Quertemont E; Litran G; Magoga C; Deblire C; Dubois N; De Roubaix J; Charlier C; Lemaître A; Ansseau M
Eur Addict Res; 2015; 21(4):179-87. PubMed ID: 25832522
[TBL] [Abstract][Full Text] [Related]
10. Craving and illicit heroin use among patients in heroin-assisted treatment.
Blanken P; Hendriks VM; Koeter MW; van Ree JM; van den Brink W
Drug Alcohol Depend; 2012 Jan; 120(1-3):74-80. PubMed ID: 21782351
[TBL] [Abstract][Full Text] [Related]
11. Familial expressed emotion among heroin addicts in methadone maintenance treatment: does it matter?
Lee CH; Wang TJ; Tang HP; Liu YH; Bell J
Addict Behav; 2015 Jun; 45():39-44. PubMed ID: 25638535
[TBL] [Abstract][Full Text] [Related]
12. Change in quality of life and its predictors in heroin users receiving methadone maintenance treatment in Taiwan: an 18-month follow-up study.
Wang PW; Wu HC; Yen CN; Yeh YC; Chung KS; Chang HC; Yen CF
Am J Drug Alcohol Abuse; 2012 May; 38(3):213-9. PubMed ID: 22352836
[TBL] [Abstract][Full Text] [Related]
13. Oral fluid results compared to self reports of recent cocaine and heroin use by methadone maintenance patients.
Cone EJ
Forensic Sci Int; 2012 Feb; 215(1-3):88-91. PubMed ID: 21377302
[TBL] [Abstract][Full Text] [Related]
14. Quality of life under maintenance treatment with heroin versus methadone in patients with opioid dependence.
Karow A; Reimer J; Schäfer I; Krausz M; Haasen C; Verthein U
Drug Alcohol Depend; 2010 Dec; 112(3):209-15. PubMed ID: 20728288
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of heroin markers in urine for pain management patients.
Knight J; Puet BL; DePriest A; Heltsley R; Hild C; Black DL; Robert T; Caplan YH; Cone EJ
Forensic Sci Int; 2014 Oct; 243():79-83. PubMed ID: 24858136
[TBL] [Abstract][Full Text] [Related]
16. Serum concentrations of macro and trace elements in heroin addicts of the Canary Islands.
Díaz-Flores JF; Sañudo RI; Rodríguez EM; Romero CD
J Trace Elem Med Biol; 2004; 17(4):235-42. PubMed ID: 15139385
[TBL] [Abstract][Full Text] [Related]
17. Screening for illicit heroin use in patients in a heroin-assisted treatment program.
Rook EJ; Huitema AD; van den Brink W; Hillebrand MJ; van Ree JM; Beijnen JH
J Anal Toxicol; 2006; 30(6):390-4. PubMed ID: 16872571
[TBL] [Abstract][Full Text] [Related]
18. Erectile dysfunction among male heroin addicts receiving methadone maintenance treatment in Guangdong, China.
Chen W; Li X; Li X; Ling L; Xia Y; Chen J; He Q
J Addict Med; 2012 Sep; 6(3):212-8. PubMed ID: 22614937
[TBL] [Abstract][Full Text] [Related]
19. Deuterodiacetylmorphine as a marker for use of illicit heroin by addicts in a heroin-assisted treatment program.
Klous MG; Rook EJ; Hillebrand MJ; van den Brink W; van Ree JM; Beijnen JH
J Anal Toxicol; 2005 Sep; 29(6):564-9. PubMed ID: 16168180
[TBL] [Abstract][Full Text] [Related]
20. Staff concerns in heroin-assisted treatment centres.
Demaret I; Lemaître A; Ansseau M
J Psychiatr Ment Health Nurs; 2012 Aug; 19(6):563-7. PubMed ID: 22074590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
